Bloomberg Law
June 7, 2018, 6:35 PM

No Guidance on Right-to-Try Drugs for Months, FDA Chief Says

Adrianne Appel
Adrianne Appel
Staff Correspondent

It will be another two to three months before the FDA releases guidance or information for drug manufacturers about the nation’s new right-to-try law, Scott Gottlieb, head of the agency, said.

President Donald Trump signed the right-to-try legislation, S. 204, May 30. The measure is designed to give desperate patients access to unapproved treatments. Lawmakers and patient advocacy groups have hailed the law as one that may provide life-saving treatments to people who need it. But critics, including Public Citizen, a consumer group, say patients could be endangered by using treatments that have not been thoroughly vetted.

Directors Met

The ...

Learn more about Bloomberg Law or Log In to keep reading:

Learn About Bloomberg Law

AI-powered legal analytics, workflow tools and premium legal & business news.

Already a subscriber?

Log in to keep reading or access research tools.